Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Carlos J. Bidot"'
Autor:
Carlos J. Bidot, Ashish K. Rehni, Kunjan R. Dave, Conner R. Haase, Sebastian Koch, Wenche Jy, Vibha Shukla, Yeon S. Ahn, Hever Navarro Quero, Ensign Anise A. Crane, Shivam Patel
Publikováno v:
J Cardiovasc Pharmacol Ther
Background:Uncontrollable bleeding is a major cause of mortality and morbidity worldwide. Effective hemostatic agents are urgently needed. Red cell microparticles (RMPs) are a highly promising hemostatic agent. This study evaluated the safety profile
Publikováno v:
Clinical Case Reports and Reviews. 2
Autor:
Hever Navarro-Quero, Shivam Patel, Vibha Shukla, Carlos J. Bidot, Sebastian Koch, Wenche Jy, Ashish K. Rehni, Anise Crane, Conner R. Haase, Kunjan R. Dave, Yeon S. Ahn
Publikováno v:
Blood. 132:1044-1044
BACKGROUND: Uncontrollable bleeding is a major cause of mortality and morbidity worldwide. Effective hemostatic agents are urgently needed. Red cell microparticles (RMP) have been introduced as a promising new hemostatic agent [Thromb Haemost 2013, 1
Autor:
Joaquin J. Jimenez, Carlos J. Bidot, Wenche Jy, Lawrence L. Horstman, Yeon S. Ahn, Maike Tiede, Julio A. Chirinos
Publikováno v:
Thrombosis Research. 121:319-325
Background Anti-phospholipid antibodies (APLA) are often associated with thrombosis, defining the antiphospholipid syndrome (APS) but it remains unclear why many subjects who are positive for APLA chiefly anti-cardiolipin (aCL) or anti-β2GPI (aβ2GP
Publikováno v:
Acta Haematologica. 116:19-24
Introduction: It has been suggested that Helicobacter pylori eradication often increases platelet counts in patients with chronic idiopathic thrombocytopenic purpura (ITP). In addition, H. pylori has been shown to induce platelet activation (CD62p or
Autor:
Lawrence L. Horstman, Eugene R. Ahn, Carlos J. Bidot, Vincenzo Fontana, Yeon S. Ahn, Wenche Jy, Loreta Bidot
Publikováno v:
Hematology. 10:451-456
Risk factors for thrombosis (TB) in thrombocythaemia (TC) associated with myeloproliferative disorder (MPD) are not well defined.We measured antiphospholipid antibodies (APLA) in 35 patients with TC associated with MPD. Fourteen had TB and 21 did not
Autor:
Yeon S. Ahn, Wenche Jy, Joaquin J. Jimenez, Lawrence L. Horstman, Thomas Scagnelli, Maike Tiede, Eugene R. Ahn, Carlos J. Bidot
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 11:347-352
A life-threatening hypercoagulable state (HCS) is reported that developed after splenectomy in idiopathic thrombocytopenic purpura (ITP). A 50-year-old active male was rejected for blood donation because of an incidental finding of low platelet count
Publikováno v:
The Keio Journal of Medicine. 53:210-230
Analysis of circulating cell-derived microparticles (MP) is becoming more refined and clinically useful. This review, stemming from lectures given at Tokyo late 2003, does not repeat prior reviews but focuses on new horizons. A major theme is the ris
Autor:
Gabriella Lander, Wenche Jy, Eugene R. Ahn, Joaquin J. Jimenez, Yeon S. Ahn, Lawrence L. Horstman, Carlos J. Bidot
Publikováno v:
Thrombosis Research. 114:143-148
Introduction: Soluble CD40L (sCD40L) ELISA has emerged as a promising predictor of poor outcomes in acute coronary syndrome. Yet many blood processing techniques have been used with little consideration of their effect on the results. Methods: We mea
Autor:
Joaquin J. Jimenez, Carlos J. Bidot, Wenche Jy, Lawrence L. Horstman, Miriam Yaniz, Yeon S. Ahn, Huang Huisheng
Publikováno v:
British Journal of Haematology. 120:618-626
We investigated antibodies to factor VII/VIIa (FVII/VIIa) and five other common target antigens in 33 patients with a history of anti-phospholipid syndrome (APS) and 50 healthy controls using an enzyme-linked immunosorbent assay (ELISA) technique. We